Invesaro

Stocks TNXP Earnings

Earnings

Tonix Pharmaceuticals Holding Corp. (TNXP) earnings

Quarterly results of Tonix Pharmaceuticals Holding Corp. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when TNXP files with the SEC.

Next earnings date

Tonix Pharmaceuticals Holding Corp. is expected to report around December 28, 2026. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.

Latest quarter: Q3 FY2026

In Q3 FY2026 (ended September 30, 2026) Tonix Pharmaceuticals Holding Corp. reported revenue of $17.2M (+423.8% on the same quarter a year earlier) and a net loss of $53.3M.

Diluted earnings per share were -$2.89.

Filed with the SEC on November 9, 2026.

Revenue by quarter
Q4 24: $2.6M $2.6M Q4 24Q1 25: $2.4M $2.4M Q1 25Q2 25: $2M $2M Q2 25Q3 25: $3.3M $3.3M Q3 25Q4 25: $5.4M $5.4M Q4 25Q1 26: $6.9M $6.9M Q1 26Q2 26: $13.5M $13.5M Q2 26Q3 26: $17.2M $17.2M Q3 26
Net income by quarter
Q4 24: -$22.1M -$22.1M Q4 24Q1 25: -$16.8M -$16.8M Q1 25Q2 25: -$28.3M -$28.3M Q2 25Q3 25: -$32M -$32M Q3 25Q4 25: -$46.9M -$46.9M Q4 25Q1 26: -$40.2M -$40.2M Q1 26Q2 26: -$40.6M -$40.6M Q2 26Q3 26: -$53.3M -$53.3M Q3 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q3 FY2026September 30, 2026$17.2M+423.8%-$53.3M-$2.89
Q2 FY2026June 30, 2026$13.5M+577.9%-$40.6M-$2.44
Q1 FY2026March 31, 2026$6.9M+183.2%-$40.2M-$2.93
Q4 FY2025December 31, 2025$5.4M+108.8%-$46.9M-
Q3 FY2025September 30, 2025$3.3M--$32M-$3.59
Q2 FY2025June 30, 2025$2M--$28.3M-$3.86
Q1 FY2025March 31, 2025$2.4M--$16.8M-$2.84
Q4 FY2024December 31, 2024$2.6M--$22.1M-

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Tonix Pharmaceuticals Holding Corp.'s next earnings date?

Tonix Pharmaceuticals Holding Corp. is expected to report around December 28, 2026. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.

What were Tonix Pharmaceuticals Holding Corp.'s latest quarterly results?

For Q3 FY2026, which ended September 30, 2026, Tonix Pharmaceuticals Holding Corp. reported revenue of $17.2M and a net loss of $53.3M. The figures come from its filing with the SEC.

Is Tonix Pharmaceuticals Holding Corp.'s revenue growing?

Revenue in Q3 FY2026 was $17.2M, up 423.8% from $3.3M in the same quarter a year earlier.

Get an email when TNXP reports

Follow TNXP and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when TNXP files with the SEC.

Source: quarterly figures Tonix Pharmaceuticals Holding Corp. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Tonix Pharmaceuticals Holding Corp.